The Worlds #1 Renewable Energy Network for News & Information
Sign In
or
Register
Sections
Home
Solar
Wind
Geothermal
Bio
Hydro
Careers
Companies
Webcasts
White Papers
Magazines
Awards
Account
Sign In
Register
Search
REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Bristol-Myers Squibb Co.
(NY:
BMY
)
46.05
USD
-0.80 (-1.71%)
Official Closing Price
/ Updated:
4:15 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Bristol-Myers Squibb Co.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
A Make-or-Break Week Ahead for the Stock Market
April 20, 2013
It's make-or-break time for the first-quarter earnings season, and it comes just as the stock market is showing signs of strain.
Read More
category
New York Times Co
,
Gannett Inc
,
Weyerhaeuser Co
, and 142 more.
from
CNBC.com News
At a Loss ... 'Call Me, Faber' ... Rat-Sized Snails Attack!
April 19, 2013
Our "Talking Squawk" blog is meant to be a funny, sarcastic look ahead and back at business news through the unique "Squawk Box" lens. But at times this week, it was difficult to think about anything...
Read More
category
Apple Inc
,
Sprint Nextel Corp
,
Citigroup Inc
, and 38 more.
from
CNBC.com News
4 Pharmaceutical Stocks to Buy Now
April 19, 2013
Read More
category
NYSE:JNJ
,
NYSE:WPI
,
Stocks to Buy
, and 2 more.
from
InvestorPlace - Latest Headlines
Noteworthy ETF Inflows: USMV, AMGN, BMY, GIS
April 18, 2013
Symbols mentioned in this story: USMV, AMGN, BMY, GIS Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
Next Support Level for Bristol-Myers Squibb (BMY) is $40.24
April 18, 2013
from
Comtex SmarTrend® News Briefs
How A Mourning Entrepreneur And A Dogged Doctor Rescued A Rare Disease Drug
April 17, 2013
When Marc Beer sold his first public company, the biotech ViaCell, to Perkin-Elmer for $300 million in 2007 it seemed like the beginning of an amazing entrepreneurial career. But just months later it...
Read More
category
NYSE:BMY
,
NASDQ:ISIS
,
NASDAQ:AEGR
from
Forbes Real Time
Bristol-Myers Squibb Shares Up 19.6% Since SmarTrend's Buy Recommendation (BMY)
April 17, 2013
from
Comtex SmarTrend® News Briefs
UPDATE 1-Lilly diabetes drug as good as insulin in study
April 16, 2013
* Drug also showed benefits when used with other treatments
Read More
category
companyNews
from
Reuters: Company News
The Undiscovered Biotech Giant: Nuvilex
April 15, 2013
category
Pharmaceuticals
from
Trefis
Goodwill Investing: J&J Bet on Biotech Start-Ups
April 13, 2013
Johnson & Johnson is giving biotech start-ups space on the cheap, hoping if a company creates a hot new drug, they'll remember J&J.
Read More
category
Johnson and Johnson
,
Economics
,
tvcodes/tvecon
, and 2 more.
from
CNBC.com News
4 Pharmaceutical Stocks to Buy Now
April 12, 2013
Read More
category
NYSE:JNJ
,
NYSE:WPI
,
Stocks to Buy
, and 2 more.
from
InvestorPlace - Latest Headlines
Bristol-Myers Squibb Expansion to Add 350 Jobs
April 12, 2013
DailyFinance.com : Getty Images NEW YORK -- Drugmaker Bristol-Myers Squibb plans to spend about $250 million expanding a manufacturing complex it opened in 2009 for biologic treatments. The New York...
Read More
category
bmy
,
drug companies
,
biological sciences
, and 5 more.
from
DailyFinance.com
Is This Market a Bubble?
April 11, 2013
U.S. stocks logged a fourth day of gains on Thursday, with the Dow Jones Industrial Average and S&P 500 index logging fresh closing highs, prompting some on Wall Street to worry about a stock market...
Read More
category
Investing/Indexes/Dow Jones Industrial Average
,
Bristol/Myers Squibb Co
,
Mad Money for Mobile
, and 7 more.
from
CNBC.com News
ETF Showdown: A Pharma Fight
April 11, 2013
Much has been made of low volatility sectors leading U.S. equities to new all-time highs. Sectors such as consumer staples and utilities are driving the broader market higher . Health care is certainly...
Read More
category
Benzinga
,
ETFs
,
PJP
, and 22 more.
from
Latest Articles from Benzinga.com
The 10 Best Corporate Citizens
April 11, 2013
category
NASDAQ:MAT
,
NYSE:BMY
,
NYSE:T
from
Forbes Real Time
America's 100 Best Corporate Citizens
April 11, 2013
AT&T is the best corporate citizen in the U.S. right now, according to a new ranking by CR Magazine. That means it beat out everyone else in the Russell 1000 index of large-capitalization companies in...
Read More
category
NASDAQ:MAT
,
NYSE:BMY
,
NYSE:T
from
Forbes Real Time
UPDATE 2-Bristol-Myers to spend $250 mln to expand biologics facility
April 11, 2013
April 11 (Reuters) - Bristol-Myers Squibb Co said on Thursday it plans to spend $250 million to expand its Devens, Massachusetts, facility that makes large-scale biologic drugs.
Read More
category
companyNews
from
Reuters: Company News
Bristol-Myers to Expand Massachusetts Biologics Facility, to Invest $250M, Increase Workforce
April 11, 2013
Bristol-Myers Squibb (NYSE: BMY ) today announced plans for an approximately $250 million expansion of its large-scale biologics manufacturing facility in Devens, Massachusetts. The expansion will...
Read More
category
Benzinga
,
News
,
BMY
from
Latest Articles from Benzinga.com
Bristol-Myers Squibb (BMY) Breaks Through Resistance at $41.00
April 10, 2013
from
Comtex SmarTrend® News Briefs
UPDATE: Jefferies Raises PT on Bristol-Myers Squibb on Positive Outlook
April 10, 2013
In a report published Wednesday, Jefferies analyst Jeffrey Holford reiterated a Buy rating on Bristol-Myers Squibb Co. (NYSE: BMY ), and raised the price target from $41.00 to $45.00. In the report,...
Read More
category
Benzinga
,
Price Target
,
Jefferies
, and 3 more.
from
Latest Articles from Benzinga.com
CORRECTED-Roche immune therapy cancer drug shows promise in early study
April 10, 2013
(Corrects drug identifier in 2nd paragraph to MPDL3280A from MPDL320A)
Read More
category
companyNews
from
Reuters: Company News
Notable ETF Inflow Detected - USMV, BMY, AMGN, DUK
April 10, 2013
Symbols mentioned in this story: USMV, BMY, AMGN, DUK Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Read More
category
ETFs
from
ETF Channel
Bristol-Myers Squibb Up 20.2% Since SmarTrend Uptrend Call (BMY)
April 10, 2013
from
Comtex SmarTrend® News Briefs
Cramer: The Fed's 'Parlor Game' Has Cost Investors
April 10, 2013
Investors are too focused on the Federal Reserve and it's costing them, since other factors are more important for stocks, CNBC's Jim Cramer said on "Squawk on the Street" Wednesday.
Read More
category
Intel Corp
,
Squawk on the Street
,
Cummins Inc
, and 4 more.
from
CNBC.com News
Jefferies Raises Price Targets on Pharmaceutical Stocks (ABBV, ABT, BMY, more)
April 10, 2013
Jefferies analysts boosted the price target on a number of pharmaceutical companies on Wednesday, holding a positive view of the sector heading into earnings season. The analysts believe a number of...
Read More
category
bmy
,
jnj
,
abt
, and 4 more.
from
Dividend Daily
Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)
April 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8244178 for the full story.
Read More
from
StreetInsider.com News Articles
Cramer's Favorite Big Pharma Catch-Up Play
April 09, 2013
While its peers trade at 14 times earnings on average, this pharma trades at only 12 times earnings.
Read More
category
Investing
,
Eli Lilly and Company
,
Bristol/Myers Squibb Co
, and 12 more.
from
CNBC.com News
Roche immune therapy cancer drug shows promise in early study
April 09, 2013
April 9 (Reuters) - An experimental drug that spurs the immune system to fight cancer appeared to be safe and demonstrated anti-tumor activity against a variety of cancers in a small early stage study,...
Read More
category
companyNews
from
Reuters: Company News
These Are the 100 Highest-Paid CEOs in Business Today
April 08, 2013
The New York Times has published a list of the 100 highest-paid CEOS at U.S. public companies in 2012. Oracle (NASDAQ: ORCL ) chief executive Larry Ellison is far and away the highest paid CEO on the...
Read More
category
Stephen Wynn
,
VZ
,
Management
, and 166 more.
from
Latest Articles from Benzinga.com
Stocks To Watch For April 8, 2013
April 08, 2013
Some of the stocks that may grab investor focus today are: Wall Street expects Alcoa (NYSE: AA ) to report its Q1 earnings at $0.10 per share on revenue of $5.89 billion. Alcoa shares gained 0.12% to...
Read More
category
Earnings
,
Benzinga
,
MG
, and 9 more.
from
Latest Articles from Benzinga.com
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here